GEN2

N/A

Report date: 2026/03/14 20:00:17

Base Information

Drug NameGEN2
Drug Alias NameGEN 2
ClassificationBiologics
Mechanisms of ActionThymidine kinase stimulantsGene transference
TargetsThymidine kinase
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPhilippines
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenvivo Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenvivo Inc
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisCarcinoma, Hepatocellular
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A